Previous close | 25.80 |
Open | 25.30 |
Bid | 19.52 x 900 |
Ask | 23.72 x 900 |
Day's range | 23.50 - 25.44 |
52-week range | 13.19 - 76.10 |
Volume | |
Avg. volume | 665,930 |
Market cap | 1.239B |
Beta (5Y monthly) | 0.81 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
RALEIGH, N.C., July 29, 2022--Phreesia, Inc. (NYSE: PHR) ("Phreesia") today announced that it will release its fiscal second quarter 2023 financial results after the close of market trading on Wednesday, September 7, 2022. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal second quarter results
RALEIGH, N.C., July 20, 2022--Phreesia is pleased to announce that it has been named to The Software Report’s list of "The Top 100 Software Companies of 2022." The annual award recognizes the best companies leading the software industry forward, considering criteria including product quality, organizational effectiveness and management caliber.
RALEIGH, N.C., June 22, 2022--Patients’ expectations of healthcare technology are changing to reflect the digital conveniences they are used to in other aspects of their lives, according to research in a newly published white paper from Phreesia. Based on the results of a survey of 4,136 patients, the paper sheds light on the consumer-centric trends reshaping healthcare delivery and shares best practices that healthcare organizations can employ to improve patients’ experience and better engage t